JETRO Startup
Global Startup Acceleration Program (GSAP) AlumnisJ-Pharma Co., Ltd.
CIC '21 Bio/Healthcare
Healthcare Manufacturing Chemistry Biotech
From its establishment in 2005 by Hitoshi Endou, MD., PhD.,, a former professor of Kyorin University Faculty of Medicine, J-Pharma has developed a number of unique drugs into clinical stage as a company specializing in transporters in cell membranes. Today, J-Pharma is pursuing clinical development of an inhibitor of L-type amino acid transporter 1 (LAT1) for advanced cancer patients.
Profile
- Year founded
- 26-Dec-05
- Name of the representative
- Masuhiro Yoshitake / President & CEO
- HQ location（City)
- Kanagawa
- Total amount raised to date
- JPY4,488,000 / USD32.9 * updated in Mar.2023 (Unit：JPY thousand, USD mio)
- Stage
- beyond Series D
- Major investors/VCs
- JIC Venture Growth Investments, Eight Roads Ventures Japan,F-Prime Capital, Newton Biocapital Pricaf Privee SA, OHARA Pharmaceutical Co.,Ltd., SPERAPHARMA,Inc.
- Partnership
- OSAKA UNIVERSITY, YOKOHAMA CITY UNIVERSITY, Georgetown UNIVERSITY, Kanazawa University, OHARA Pharmaceutical Co.,Ltd.
- Major Clients
CEO/Team
*The contents of this page are subject to change without prior notice. Please contact us for the latest information.
